Grifols SA
MAD:GRF

Watchlist Manager
Grifols SA Logo
Grifols SA
MAD:GRF
Watchlist
Price: 10.045 EUR 0.95%
Updated: May 17, 2024
Section:
 

Relative Value

The Relative Value of one GRF stock under the Base Case scenario is hidden EUR. Compared to the current market price of 10.045 EUR, Grifols SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRF Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
84
vs Industry
88
Median 3Y
1.7
Median 5Y
2.4
Industry
8.2
Forward
0.9
More Details
113.9
P/E
P/E
Price to Earnings
113.9
vs History
7
vs Industry
1
Median 3Y
27.1
Median 5Y
23.8
Industry
27.4
Forward
18.2
More Details
32.4
P/OCF
P/OCF
Price to OCF
32.4
vs History
17
vs Industry
5
Median 3Y
19.4
Median 5Y
22
Industry
24.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
3.8
Median 5Y
5.6
Industry
23
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
84
vs Industry
59
Median 3Y
1.4
Median 5Y
2.6
Industry
2.6
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
77
vs Industry
68
Median 3Y
3.2
Median 5Y
3.6
Industry
7.5
Forward
2.1
More Details
6.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.1
vs History
76
vs Industry
52
Median 3Y
7.7
Median 5Y
7.8
Industry
9.3
More Details
13
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13
vs History
76
vs Industry
9
Median 3Y
15.6
Median 5Y
14.6
Industry
4.3
Forward
8.4
More Details
20.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.8
vs History
39
vs Industry
6
Median 3Y
20.9
Median 5Y
19.6
Industry
4.2
Forward
11.9
More Details
73.5
EV/OCF
EV/OCF
Enterprise Value to OCF
73.5
vs History
9
vs Industry
2
Median 3Y
26.9
Median 5Y
30.8
Industry
5.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-153.9
Median 5Y
32.2
Industry
3.3
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
87
vs Industry
63
Median 3Y
0.9
Median 5Y
1.3
Industry
4.9
More Details

Multiples Across Competitors

GRF Competitors Multiples
Grifols SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Grifols SA
MAD:GRF
6.8B EUR 1 113.9 13 20.8
US
Abbvie Inc
NYSE:ABBV
290.2B USD 5.3 60.2 13.1 19.9
US
Amgen Inc
NASDAQ:AMGN
168.8B USD 5.7 44.9 18.9 31.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 11.5 31.4 25.4 26.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
106.7B USD 8.1 27.7 22.3 24.8
AU
CSL Ltd
ASX:CSL
138.6B AUD 6.4 36.6 22.6 28
US
Gilead Sciences Inc
NASDAQ:GILD
84.6B USD 3.1 174.7 7 9.2
US
Moderna Inc
NASDAQ:MRNA
50.8B USD 9.9 -8.5 -9.4 -8.3
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.5B USD 3.5 28.7 14.6 18.2
KR
Celltrion Inc
KRX:068270
39.4T KRW 18.1 73.6 45 62

See Also

Summary
GRF intrinsic value, competitors valuation, and company profile.
DCF Valuation
GRF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GRF stock valuation using valuation multiples.
Wall Street Estimates
GRF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GRF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.